AsclepiX Therapeutics
Jeffrey Heier is the Co-President-Medical Director, Director of Vitreoretinal Service & Director of Retina Research at Ophthalmic Consultants of Boston.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
AsclepiX Therapeutics
1 followers
AsclepiX Therapeutics is revolutionizing the treatment of retinal diseases and cancer with a singular focus on the design, development, and delivery of novel peptides with the power to inhibit proven key disease pathways. Their peptide drug candidates tap into the body’s powerful mechanisms of maintaining homeostasis, the fundamental principle of biology to seek and maintain a condition of equilibrium or stability.